Filitra is a medication containing Vardenafil, a PDE5 inhibitor used to treat erectile dysfunction (ED). Like all medications, Filitra can have potential side effects. These side effects are typically reported by a combination of healthcare professionals, patients, and drug manufacturers to ensure safety and proper usage. Who Reports Filitra Side Effects? 1. Healthcare Providers Doctors, pharmacists, and other medical professionals are often the first to report side effects. They observe the effects of the drug during their treatment of patients and may report any adverse reactions they notice. Healthcare providers can report side effects to regulatory agencies, such as the FDA (U.S. Food and Drug Administration) in the U.S. or the EMA (European Medicines Agency) in Europe. These reports help agencies monitor the safety of medications. 2. Patients (Direct Reports) Patients who experience side effects from Filitra may report them directly to their healthcare providers. Many healthcare systems also allow patients to report side effects to national health agencies. For example, in the U.S., patients can report side effects to the FDA's MedWatch program, which collects safety data on medications. 3. Pharmaceutical Companies Filitra's manufacturer or the company responsible for producing the drug has a legal obligation to track and report any known adverse events associated with their products. These companies are required to maintain a system for monitoring drug safety and report any serious side effects or adverse events to the regulatory authorities. This includes both rare and common side effects that may not have been identified during initial clinical trials.